Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Journal
    Print Access Request
    Location
    Version
    Call Number
    Items
    Stored offsite. Please request print.
    23
  • Article
    Hedbäck B, Nordenfelt I, Svanström B, Vedin A, Wilhelmsson C, Oberg K.
    Ann Clin Res. 1977 Oct;9(5):305-10.
    The efficacy and toleration of a new beta1-selective beta-blocker, H 87/07, was compared with placebo in 33 patients with angina pectoris. The efficacy was evaluated using subjective assessments of attack rate and nitroglycerin consumption as well as objective assessments of exercise tolerance on a bicycle ergometer. H 87/07 significantly reduced the attack rate and the nitroglycerin consumption compared with placebo. The mean reduction amounted to 13 and 36% respectively. No significant differences were found between H 87/07 and placebo with regard to exercise tolerance. Due to high intrinsic stimulating activity (I.S.A.) H 87/07 altered the heart rate and blood pressure only slightly at rest but during exercise significant reductions were seen. Except for one patient who had cardiac decompensation on H 87/07 no side-effects of clinical importance were seen. No significant changes were seen with regard to the laboratory tests performed.
    Digital Access Access Options
  • Book
    by William Beebe.